Antidepressant use in Alzheimer's disease patients: Results of the REAL.FR cohort

International Psychogeriatrics

Volumn 22, Issue 1, 2010, Pages 120-128

  Arbus, Christophe ^a   Gardette, Virginie ^b   Bui, Eric ^a   Cantet, Christelle ^b   Andrieu, Sandrine ^b   Nourhashémi, Fati ^b,c   Schmitt, Laurent ^a   Vellas, Bruno ^b,c  

^a Toulouse University   (France)

^b INSERM   (France)

^c Gerontopole   (France)

Author keywords

Behavioral and psychological symptoms; Community dwelling; Dementia; Depressive symptoms; Psychotropics

Indexed keywords

ANTIDEPRESSANT AGENT;

AGED; AGGRESSION; AGITATION; ALZHEIMER DISEASE; ANAMNESIS; ARTICLE; DEMOGRAPHY; DEPRESSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL PATIENT; MULTIVARIATE ANALYSIS; POPULATION; PRESCRIPTION; PREVALENCE; PROSPECTIVE STUDY; PSYCHOSIS; SYMPTOM;

AGED; ALZHEIMER DISEASE; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MENTAL DISORDERS; PROSPECTIVE STUDIES; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX;

EID: 75149169206     PISSN: 10416102     EISSN: 1741203X     Source Type: Journal    
DOI: 10.1017/S1041610209990780     Document Type: Article

References (29)

1. Aalten, P., de Vugt, M. E., Jaspers, N., Jolles, J. and Verhey, F. R. (2005). The course of neuropsychiatric symptoms in dementia. Part I: Findings from the two-year longitudinal Maasbed study. International Journal of Geriatric Psychiatry, 20, 523-530.
2. Arbus, C. et al. (2008). The prevalence of clinically significant depressive symptoms in Alzheimer's disease: relationship with other psychological and behavioral symptoms. International Journal of Geriatric Psychiatry, 23, 1209-1211.
3. Borson, S., Scanlan, J. M., Doane, K. and Gray, S. (2002). Antidepressant prescribing in nursing homes: is there a place for tricyclics? International Journal of Geriatric Psychiatry, 17, 1140-1145.
4. Burke, W. J., Dewan, V., Wengel, S. P., Roccaforte, W.H., Nadolny, G. C. and Folks,D.G. (1997). The use of selective serotonin reuptake inhibitors for depression and psychosis complicating dementia. International Journal of Geriatric Psychiatry, 12, 519-525.
5. Cummings, J. L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D. A. and Gornbein, J. (1994). The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology, 44, 2308-2314.
6. Gillette-Guyonnet, S. et al. (2003). The REAL.FR research program on Alzheimer's disease and its management: methods and preliminary results. Journal of Nutrition, Health and Aging, 7, 91-96.
7. Gottfries, C. G., Karlsson, I. and Nyth, A. L. (1992). Treatment of depression in elderly patients with and without dementia disorders. International Journal of Clinical Psychopharmacology, 6 (Suppl. 5), 55-64.
8. Hughes, C. P., Berg, L.,Danziger, W. L., Coben, L. A. and Martin, R. L. (1982). A new clinical scale for the staging of dementia. British Journal of Psychiatry, 140, 566-572.
9. Katz, S., Ford, A. B., Moskowitz, R. W., Jackson, B. A. and Jaffe, M. W. (1963). Studies of illness in the aged. The index of Adl: a standardized measure of biological and psychosocial function. JAMA, 185, 914-919.
10. Lanctôt, K. L.,Herrmann, N., Eryavec,G., van Reekum, R., Reed, K. and Naranjo, C. A. (2002). Central serotonergic activity is related to the aggressive behaviors of Alzheimer's disease. Neuropsychopharmacology, 27, 646-654.
11. Lawton, M. P. and Brody, E.M. (1969). Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist, 9, 179-186.
12. Lopez, O. L. et al. (2003). Patterns of change in the treatment of psychiatric symptoms in patients with probable Alzheimer's disease from 1983 to 2000. Journal of Neuropsychiatry and Clinical Neuroscience, 15, 67-73.
13. Lyketsos, C. G., Breitner, J. C. and Rabins, P. V. (2001). An evidence-based proposal for the classification of neuropsychiatric disturbance in Alzheimer's disease. International Journal of Geriatric Psychiatry, 16, 1037-1042.
14. Margallo-Lana, M. et al. (2001). Prevalence and pharmacological management of behavioral and psychological symptoms amongst dementia sufferers living in care environments. International Journal of Geriatric Psychiatry, 16, 39-44.
15. Meltzer, C. C. et al. (1998). Serotonin in aging, late-life depression, and Alzheimer's disease: the emerging role of functional imaging. Neuropsychopharmacology, 18, 407-430.
16. Pollock, B. G. et al. (2002). Comparison of citalopram, perphenazine, and placebo for the acute treatment of psychosis and behavioral disturbances in hospitalized, demented patients. American Journal of Psychiatry, 159, 460-465.
17. Rigler, S. K., Webb, M. J., Redford, L., Brown, E. F., Zhou, J. and Wallace, D. (2001). Weight outcomes among antidepressant users in nursing facilities. Journal of the American Geriatrics Society, 49, 49-55.
18. Robert, P., Medecin, I. and Vincent, S. (1998). L'inventaire neuropsychiatrique: validation de la version française d'un instrument destińe ̀a ́evaluer les troubles du comportement chez le sujet d́ement. L'Anńee Ǵerontologique, 5, 63-86.
19. Rosen, W. G., Mohs, R. C. and Davis, K. L. (1984). A new rating scale for Alzheimer's disease. American Journal of Psychiatry, 141, 1356-1364.
20. Rosenberg, P. B., Mielke, M. M. and Lyketsos, C. G. (2005). Caregiver assessment of patients' depression in Alzheimer disease: longitudinal analysis in a drug treatment study. American Journal of Geriatric Psychiatry, 13, 822-826.
21. Salzman, C. et al. (2008). Elderly patients with dementia-related symptoms of severe agitation and aggression: consensus statement on treatment options, clinical trials methodology, and policy. Journal of Clinical Psychiatry, 69, 889-898.
22. Schneider, L. S. et al. (2001). National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer disease trial methodology. American Journal of Geriatric Psychiatry, 9, 346-360.
23. Schneider, L. S. et al. (2006). Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. New England Journal of Medicine, 355, 1525-1538.
24. Selbaek, G., Kirkevold, O. and Engedal, K. (2008). The course of psychiatric and behavioral symptoms and the use of psychotropic medication in patients with dementia in Norwegian nursing homes: a 12-month follow-up study. American Journal of Geriatric Psychiatry, 16, 528-536.
25. Starkstein, S. E., Mizrahi, R. and Garau, L. (2005). Specificity of symptoms of depression in Alzheimer disease: a longitudinal analysis. American Journal of Geriatric Psychiatry, 13, 802-807.
26. Steffens, D. C. et al. (2000). Prevalence of depression and its treatment in an elderly population: the Cache County Study. Archives of General Psychiatry, 57, 601-607.
27. Thompson, S., Herrmann, N., Rapoport, M. J. and Lanctot, K. L. (2007). Efficacy and safety of antidepressants for treatment of depression in Alzheimer's disease: a metaanalysis. Canadian Journal of Psychiatry, 52, 248-255.
28. Vellas, B. et al. (1999). The Mini Nutritional Assessment (MNA) and its use in grading the nutritional state of elderly patients. Nutrition, 15, 116-122.
29. Zarit, S. H., Reever, K. E. and Bach-Peterson, J. (1980). Relatives of the impaired elderly: correlates of feelings of burden. Gerontologist, 20, 649-655.